Cannabidiol Oil for Decreasing Addictive Use of Marijuana: A Case Report. Shannon S(1), Opila-Lehman J(1). Author information: (1)is a psychiatrist; and is a. “This case study illustrates the use of cannabidiol (CBD) oil to decrease the addictive use of marijuana and provide anxiolytic and sleep. “How could you even use CBD for addiction? In a recent case study, researchers ran a series of tests to determine the “anti-relapse” potential.
Use Cannabidiol Oil Marijuana: of Decreasing for Report Addictive A Case
To determine potential therapeutic effects of cannabis, NASEM reviewed clinical trials designed to investigate the effects of cannabis or cannabinoids on specific conditions. As previously mentioned, the federal classification of cannabis as a Schedule I drug severely limits research activities and types of study material cannabis products eligible for therapeutic cannabis research in the U. There have been no controlled clinical studies of specific cannabis products available in U.
NASEM concluded that cannabis or cannabinoids are modestly effective for adults with the following conditions when administered via specific routes: This does not include edibles or other oral forms of cannabis available in dispensaries.
NASEM also concluded there was inadequate information to assess the therapeutic effects of cannabis or cannabinoids for all the other conditions that were evaluated: Though clinical trials have shown that cannabis is effective at reducing pain symptoms in adults, the efficacy and safety of current forms of cannabis and cannabinoids available in U. Given that pain is the most commonly cited reason for medicinal cannabis use by patients, 29 it is likely that more adults will self-treat their chronic pain with cannabis.
However, whether cannabis should be considered as a non-opioid therapy for chronic pain remains unclear despite recent reports suggesting that cannabis administration may reduce the use of opioid-based pain medications. Although there is a lack of evidence supporting the use of cannabis or cannabinoids for other conditions that were evaluated, some are listed by the MBC as debilitating conditions that qualify the patient for a medical marijuana recommendation e.
MBC states that due to the lack of evidence of efficacy in the treatment of certain conditions, physicians should use their professional discretion and base medicinal cannabis recommendations on informed and shared decision making with their patients. To ascertain the impacts of non-medicinal cannabis use on health, NASEM reviewed epidemiologic studies investigating the associations and risk factors of smoked cannabis and various health conditions.
The table below features the key highlights regarding these health effects. Bolded findings had the most significant evidence base for harm. There are important limitations to these findings. The conclusions are based on epidemiologic studies that show associations but cannot confirm causality.
Moreover, these studies generally examined non-medicinal use, which may entail different patterns of use and different levels of THC and CBD compared with medicinal cannabis use. In addition, the findings may not be generalizable to cannabis available for legal purchase today. As smoked cannabis was the only delivery route examined in these studies, these effects may not apply to other forms of cannabis consumption.
In addition, it is unknown if and to what degree contaminants contributed to the observed effects. Contaminants in cannabis are prevalent and have poorly understood health effects. Health Effects of Cannabis Use Summary of Other Health Effects.
NASEM found significant evidence of adverse effects associated with non-medicinal cannabis use across many health categories. In particular, cannabis users are at a higher risk of motor vehicle crashes and substance use disorders.
In pregnancy, cannabis use is linked to low birth weight in infants. In addition, cannabis use during adolescence is associated with substantial risks including addiction and adverse impacts on academic achievement, employment, and social functioning. Other Adverse Health Findings. There are other adverse health findings related to cannabis that were not described in the NASEM report, including cannabis use disorder, 36 cannabis withdrawal syndrome, 37 and a newly described cannabinoid hyperemesis syndrome.
Asking Patients About Cannabis Use. It is important for healthcare providers to ask their patients about cannabis use in a non-judgmental manner, and to provide unbiased and evidence-based information. Affirmative answers should be followed up with questions about how they consume the products and the frequency of use. Due to the association between addiction and cannabis, providers are encouraged to ask cannabis users if they think their cannabis use is causing problems.
If the patient responds affirmatively and is amenable to treatment, a referral for substance use disorder treatment is generally warranted.
Medical providers should be aware that patients may be consuming cannabis via various routes, such as smoking, vaporizing, eating, drinking, and dermal application Figure 2. It is important that healthcare providers are prepared to discuss the risks of cannabis use and how adults can use cannabis responsibly, if they choose to use it.
Below are key counseling points with links to more detailed information and resources. Cannabis Counseling Points and Resources. Cannabis use is discouraged among women who are pregnant, breastfeeding, or contemplating pregnancy. Protect infants and children from cannabis exposure including secondhand smoke and unintentional poisoning from edibles and other products such as patches and tinctures.
It is illegal for anyone under 21 years of age to smoke, consume, buy, or possess non-medicinal cannabis. Cannabis has several negative effects in youth. Do not drive when under the influence of cannabis.
Driving while under the influence DUI of cannabis is unsafe and illegal. Cannabis use prior to driving increases the risk of being involved in a motor vehicle crash. Be aware of high levels of THC. Many cannabis plants now have higher amounts of THC and newer methods of consuming cannabis e. Be aware of synthetic cannabinoids e. Synthetic cannabinoids are not cannabis and are often more dangerous. Be aware of contaminants in cannabis products.
Advise patients to only purchase cannabis products from licensed dispensaries. Be aware that there are legal limits for medicinal and non-medicinal cannabis use, and that penalties are associated with exceeding limits. Limits are higher for medicinal use. Be aware that cannabis may impact immigration status. Cannabis is still illegal at the federal level and may have repercussions on immigration status for patients.
The wide availability of cannabis is a significant public health concern, particularly for vulnerable populations such as adolescents and pregnant women. Though evidence is limited for the impact of cannabis on most conditions, research in adults suggests clinical benefit for three conditions: The MBC has issued guidelines for the recommendation of cannabis for medicinal purposes, while allowing physicians to use their clinical judgment to decide on the appropriateness of medicinal cannabis for their patients.
However, cannabis has been associated with an array of harmful health effects and may cause certain drug interactions. Therefore, medical providers should routinely ask patients about their use of cannabis and be prepared to have informed conversations with patients about the possible health effects of cannabis and illegal synthetic cannabinoids.
Finally, providers should stay abreast of the ever-growing body of research on cannabis, as the evidence of the health impacts of cannabis use is sure to evolve and expand. To obtain CME click here. Also in this issue: Resources for Providers and Patients. The authors would like to thank the following people for their contributions: Article review and feedback: Rx for Prevention, September-October;8 5.
September 13, Updated: This article is designed to educate health care providers on the most clinically relevant cannabis issues and covers the following topics: Terminology Cannabis is the scientific name for marijuana.
Legal Status California became the first state in the United States to legalize medicinal cannabis with the Compassionate Use Act in Medical and Legal Considerations There are several medical and legal considerations health care providers should be aware of regarding cannabis.
California physicians cannot dispense or prescribe Schedule I drugs such as cannabis, but they can recommend cannabis to patients. FDA-approved cannabinoids are not Schedule I drugs and can be prescribed. A minor who is a parent of a qualified patient can be designated the primary caregiver and obtain a Medical Marijuana Identification Card to purchase cannabis for that child. In addition, the cards authorize the use, possession, and transport of medicinal cannabis in California. Fred, thank you for your review.
I am also a member of NA and AA and was worried about taking this product. I still worry that I like it so much and have often taken too much to were I was sedated but very relaxed and less irritable. It is good to know that other recovering addicts benefit from this product.
Is it legal to purchase? Where would you go to find out? At times, the politics around legalization has caused problems in studying its medical uses. Cannabis use through smoking or non-medical preparations can have many risks, especially in the developing brains of adolescents. Cannabis is a complex substance containing up to chemicals, including cannabinoid compounds, of which the majority have unknown effects, interactions and side effects. Studying the components in medical settings and for treatment of certain conditions requires purification and isolation of specific compounds.
Uniformity of dosage and administration are critical in order to confidently investigate the potential benefits and side effects of medicinal use. This article seeks to summarize the latest scientific findings on CBD and to clarify some misconceptions. CBD stands for Cannabidiol. It is important to make a distinction between CBD and the well-known cannabis sativa plant, which most people think of as marijuana.
In truth, the whole plant contains many other compounds, such as THC Delta9-Tetrahydrocannabinol , which is the primary psychoactive component. By contrast, CBD is non-psychoactive. CBD works on a cannabinoid signaling system in the brain, which is found in both invertebrates and advanced vertebrates called the endocannabinoid system. This signaling system plays a role in regulating pleasure, memory, thinking, concentration, body movement, awareness of time, appetite, pain, and sensory processing as well as brain development.
CBD appears to have a neuroprotective and anti-inflammatory effect on the brain, leading researchers to look at many applications in medicine for a number of disorders. CBD Oil has been shown to have many potential benefits , including anxiety relief, anti-seizure effects for epilepsy, neuroprotective effects for the brain, pain relief, and cancer treatment. Cannabidiol does not cause the high associated with the more well-known compound THC.
CBD is non-psychoactive and thus may deliver considerable benefits without the adverse effects associated with marijuana as it is commonly used. CBD is not addictive. In fact, it has been studied as an intervention for addictive behaviors, given that it might have may have therapeutic properties on opioid, cocaine, and psychostimulant addiction.
A review of the scientific data shows that generally, cannabidiol is considered safe for some clinical indications. It has comparatively fewer side effects than most prescription medications. The majority of the research has occurred in patients with treatment-resistant epilepsy and psychotic disorders.
Much more research is needed in human trials to determine its safety for other disease states and indications. Also, animal research shows that effectiveness is highly dose-dependent so it is important to pay close attention to the instructions for use. The most commonly reported side effects of cannabinoids are tiredness, diarrhea and changes in appetite or weight.
Additional clinical trials and safety profiles are needed for many conditions that have not yet been adequately studied in humans.
Research on chemical compounds always begins in the lab, typically in vitro before it even gets to animal models or to humans. The biochemical mechanisms of the compound must be well determined in order to more safely perform research with living organisms.
What the Science Says: CBD Clinical Trials
Fourteen studies were finally included (five case reports, one .. Cannabidiol oil for decreasing addictive use of marijuana: a case report. Addiction In animal studies, CBD was found to have an impact on the A study of 24 smokers who wished to stop smoking and used an inhaler showed Other single case studies have been documented on cannabis-related to examine whether medical marijuana reduces opioid use among. Opioids; CBD; CBD Oil; Long-Term Marijuana Use; Where and How to Buy; Dispensaries According to a report from the National Academies of the Some individuals use marijuana instead of addictive opioids to treat pain. In these cases, marijuana may actually be responsible for a decrease in.